60 related articles for article (PubMed ID: 33283233)
1. Acute Myeloid Leukemia Case Harboring Unusual FLT3 Variant: Somatic vs Germline?
Singh N; Morlote D; Vnencak-Jones C; Papadantonakis N; Harada S
Lab Med; 2021 May; 52(3):e53-e56. PubMed ID: 33283233
[TBL] [Abstract][Full Text] [Related]
2. Acute Myeloid Leukemia and Next-Generation Sequencing Panels for Diagnosis: A Comprehensive Review.
Chaudhary S; Chaudhary P; Ahmad F; Arora N
J Pediatr Hematol Oncol; 2024 Apr; 46(3):125-137. PubMed ID: 38447075
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and prognostic implications of RAS mutations in newly diagnosed acute myeloid leukemia with normal karyotype based on next-generation sequencing analysis].
Liang HZ; Ma YP; Yang LH; Guo QH; Wang SF; Li C
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):762-766. PubMed ID: 38049321
[No Abstract] [Full Text] [Related]
4. Combinatorial treatment with menin and FLT3 inhibitors induces complete remission in AML models with activating FLT3 mutations.
Miao H; Kim E; Chen D; Purohit T; Kempinska K; Ropa J; Klossowski S; Trotman W; Danet-Desnoyers G; Cierpicki T; Grembecka J
Blood; 2020 Dec; 136(25):2958-2963. PubMed ID: 33331926
[No Abstract] [Full Text] [Related]
5. FLT3 inhibitors in acute myeloid leukaemia: assessment of clinical effectiveness, adverse events and future research-a systematic review and meta-analysis.
Majothi S; Adams D; Loke J; Stevens SP; Wheatley K; Wilson JS
Syst Rev; 2020 Dec; 9(1):285. PubMed ID: 33287892
[TBL] [Abstract][Full Text] [Related]
6. The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation-positive relapsed/refractory acute myeloid leukemia.
Altman JK; Perl AE; Hill JE; Rosales M; Bahceci E; Levis MJ
Cancer Med; 2021 Feb; 10(3):797-805. PubMed ID: 33340276
[TBL] [Abstract][Full Text] [Related]
7. Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
Maziarz RT; Levis M; Patnaik MM; Scott BL; Mohan SR; Deol A; Rowley SD; Kim DDH; Hernandez D; Rajkhowa T; Haines K; Bonifacio G; Rine P; Purkayastha D; Fernandez HF
Bone Marrow Transplant; 2021 May; 56(5):1180-1189. PubMed ID: 33288862
[TBL] [Abstract][Full Text] [Related]
8. A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN.
Xiao W; Miles LA; Bowman RL; Durani V; Tian HS; DelGaudio NL; Mishra T; Zhu M; Zhang Y; Stump SE; Tallman MS; Levine RL; Cai SF
Blood Adv; 2020 Dec; 4(23):6034-6038. PubMed ID: 33284943
[TBL] [Abstract][Full Text] [Related]
9. The Bone-Forming Properties of Periosteum-Derived Cells Differ Between Harvest Sites.
Groeneveldt LC; Herpelinck T; Maréchal M; Politis C; van IJcken WFJ; Huylebroeck D; Geris L; Mulugeta E; Luyten FP
Front Cell Dev Biol; 2020; 8():554984. PubMed ID: 33324630
[TBL] [Abstract][Full Text] [Related]
10. Collagen maturity and mineralization in mesenchymal stem cells cultured on the hydroxyapatite-based bone scaffold analyzed by ATR-FTIR spectroscopic imaging.
Gieroba B; Przekora A; Kalisz G; Kazimierczak P; Song CL; Wojcik M; Ginalska G; Kazarian SG; Sroka-Bartnicka A
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111634. PubMed ID: 33321672
[TBL] [Abstract][Full Text] [Related]
11. Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice.
Boukelmoune N; Laumet G; Tang Y; Ma J; Mahant I; Singh SK; Nijboer C; Benders M; Kavelaars A; Heijnen CJ
Brain Behav Immun; 2021 Mar; 93():43-54. PubMed ID: 33316379
[TBL] [Abstract][Full Text] [Related]
12. MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus.
Bulaeva E; Pellacani D; Nakamichi N; Hammond CA; Beer PA; Lorzadeh A; Moksa M; Carles A; Bilenky M; Lefort S; Shu J; Wilhelm BT; Weng AP; Hirst M; Eaves CJ
Blood; 2020 Dec; 136(24):2764-2773. PubMed ID: 33301029
[TBL] [Abstract][Full Text] [Related]
13. Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures.
Martina Z; Christina H; Le L; Jesse DC; Liang YC; Christian SM; Monaghan AG; Kennedy AA; Yesselman JD; Gifford RR; Tai AW; Kutluay SB; Li ML; Brewer G; Tolbert BS; Hargrove AE
bioRxiv; 2020 Dec; ():. PubMed ID: 33299997
[TBL] [Abstract][Full Text] [Related]
14. Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing.
Abelson S; Zeng AGX; Nofech-Mozes I; Wang TT; Ng SWK; Minden MD; Pugh TJ; Awadalla P; Shlush LI; Murphy T; Chan SM; Dick JE; Bratman SV
Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33298453
[TBL] [Abstract][Full Text] [Related]
15. SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells.
Wang N; Weng J; Xia J; Zhu Y; Chen Q; Hu D; Zhang X; Sun R; Feng J; Minato N; Gong Y; Su L
Stem Cell Res; 2020 Dec; 49():102099. PubMed ID: 33296812
[TBL] [Abstract][Full Text] [Related]
16. The Halastavi árva Virus Intergenic Region IRES Promotes Translation by the Simplest Possible Initiation Mechanism.
Abaeva IS; Vicens Q; Bochler A; Soufari H; Simonetti A; Pestova TV; Hashem Y; Hellen CUT
Cell Rep; 2020 Dec; 33(10):108476. PubMed ID: 33296660
[TBL] [Abstract][Full Text] [Related]
17. Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis.
Fan H; Atiya HI; Wang Y; Pisanic TR; Wang TH; Shih IM; Foy KK; Frisbie L; Buckanovich RJ; Chomiak AA; Tiedemann RL; Rothbart SB; Chandler C; Shen H; Coffman LG
Cell Rep; 2020 Dec; 33(10):108473. PubMed ID: 33296650
[TBL] [Abstract][Full Text] [Related]
18. Aging and leukemic evolution of hematopoietic stem cells under various stress conditions.
Kurosawa S; Iwama A
Inflamm Regen; 2020 Nov; 40(1):29. PubMed ID: 33292805
[TBL] [Abstract][Full Text] [Related]
19. Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia.
Sun J; Yu W; Zhang X
Biomark Res; 2020 Nov; 8(1):62. PubMed ID: 33292784
[TBL] [Abstract][Full Text] [Related]
20. Forkhead-box A3 (FOXA3) represses cancer stemness and partially potentiates chemosensitivity by targeting metastasis-associated in colon cancer 1 (MACC1) signaling pathway in colorectal cancer cells.
Li N; Li Y; Gao H; Li J; Ma X; Liu X; Gong P; Cui X; Li Y
Curr Cancer Drug Targets; 2020 Dec; ():. PubMed ID: 33292133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
